Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 12.26 is in line with its 5-year average of 12.81, around the middle of its 5-year range (6.75–21.43).
As of the fiscal period ended Tuesday, June 30, 2026. 16.22% above its 12-month average of 10.55.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.26.
CURRENT RATIO
12.26
CURRENT RATIO AVG TTM
10.55
CURRENT RATIO AVG 3Y
11.40
CURRENT RATIO AVG 5Y
12.81
CURRENT RATIO AVG 10Y
8.53
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+16.22%
CURRENT VS 3Y AVG
+7.55%
CURRENT VS 5Y AVG
-4.35%
CURRENT VS 10Y AVG
+43.66%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.49
median of 706 covered companies
CURRENT VS SECTOR MEDIAN
+251.68%
vs the sector median at left
Market Cap
$116.35M
Current Ratio
13.40
TTM Avg
10.04
3Y Avg
7.53
5Y Avg
8.95
Market Cap
$116.34M
Current Ratio
3.36
TTM Avg
3.23
3Y Avg
4.24
5Y Avg
6.08
Market Cap
$116.89M
Current Ratio
2.00
TTM Avg
1.45
3Y Avg
1.62
5Y Avg
1.71
Market Cap
$110.95M
Current Ratio
12.63
TTM Avg
12.83
3Y Avg
15.22
5Y Avg
15.22
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MaxCyte, Inc. (MXCT) | $114.08M | 12.26 | 10.55 | 11.40 | 12.81 |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.36M | 1.33 | 1.19 | 1.50 | 3.26 |
| Coya Therapeutics, Inc. (COYA)vs › | $116.35M | 13.40 | 10.04 | 7.53 | 8.95 |
| Genelux Corporation (GNLX)vs › | $116.59M | 2.39 | 3.50 | 2.69 | 1.97 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $116.34M | 3.36 | 3.23 | 4.24 | 6.08 |
| BGM Group Ltd. (BGM)vs › | $111.14M | 1.25 | 2.31 | 3.27 | 2.89 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $116.89M | 2.00 | 1.45 | 1.62 | 1.71 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.95M | 12.63 | 12.83 | 15.22 | 15.22 |
| Immunic, Inc. (IMUX)vs › | $110.27M | 5.05 | 1.26 | 3.56 | 6.57 |
| Caribou Biosciences, Inc. (CRBU)vs › | $117.53M | 6.49 | 6.44 | 8.52 | 8.53 |
Current Ratio
12.26
Quick Ratio
11.47
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 12.26 |
| 2026-03-31 | 12.04 |
| 2025-12-31 | 8.30 |
| 2025-09-30 | 7.74 |
| 2025-06-30 | 12.39 |
| 2025-03-31 | 12.23 |
| 2024-12-31 | 10.88 |
| 2024-09-30 | 9.81 |
| 2024-06-30 | 14.31 |
| 2024-03-31 | 13.26 |
| 2023-12-31 | 10.65 |
| 2023-09-30 | 12.87 |
| 2023-06-30 | 17.92 |
| 2023-03-31 | 14.81 |
| 2022-12-31 | 16.35 |
| 2022-09-30 | 15.05 |
| 2022-06-30 | 14.24 |
| 2022-03-31 | 17.09 |
| 2021-12-31 | 17.32 |
| 2021-09-30 | 21.43 |
| 2021-06-30 | 6.75 |
| 2021-03-31 | 7.74 |
| 2020-12-31 | 3.90 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 5.11 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.62 |
| 2019-09-30 | 2.62 |
| 2019-06-30 | 2.64 |
| 2019-03-31 | 2.64 |
| 2018-12-31 | 3.42 |
| 2018-09-30 | 3.42 |
| 2018-06-30 | 4.40 |
| 2018-03-31 | 4.40 |
| 2017-12-31 | 4.22 |
| 2017-09-30 | 4.78 |
| 2017-06-30 | 5.40 |
| 2017-03-31 | 5.40 |
| 2016-12-31 | 2.79 |
| 2016-09-30 | 2.79 |
| 2016-06-30 | 3.82 |
| 2016-03-31 | 3.82 |
| 2015-12-31 | 1.22 |
| 2015-09-30 | 1.22 |
| 2015-06-30 | 5.15 |
| 2015-03-31 | 1.73 |
| 2014-12-31 | 1.41 |
| 2014-09-30 | 1.42 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
